Knight Capital Group Adds European Equities and Foreign Exchange Capabilities to Knight Direct EMS
23 Abril 2008 - 5:00AM
PR Newswire (US)
Additional capabilities cater to U.S. and European institutional
traders seeking one-stop multiple asset class execution management
system LONDON, and JERSEY CITY, N.J., April 23
/PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE)
announced today enhancements to its electronic trading platform,
Knight Direct EMS, that give institutional traders the ability to
trade European equities and foreign currencies. A broker-neutral
trading platform, Knight Direct EMS offers direct market access to
multiple asset classes, including U.S. and non-U.S. equities,
futures, options and foreign exchange. "Knight offers an expansive
solution for electronic, global trading including direct market
access to major European exchanges, low-latency market data and a
host of sophisticated functionality such as portfolio trading,"
said Joseph Wald, Managing Director, Direct Trading Institutional,
L.P., a subsidiary of Knight Capital Group. "Institutional traders
seeking self-directed connectivity to a wide range of liquidity
destinations in a post-MiFID environment can look to our expertise
and technology to address their needs." With direct market access
to most European exchanges, Knight Direct EMS offers native
functionality in each exchange and market, giving U.S. and European
traders powerful liquidity management solutions in dealing with
fragmentation of the European equities marketplace. In addition to
the European equities trading capabilities, Knight has added
electronic access to the spot foreign exchange market through
subsidiary Hotspot FX, making Knight Direct EMS a virtual one-stop
shop for flexible trading capabilities in multiple asset classes.
Hotspot provides access to trading in 48 currency pairs as well as
gold and silver through a transparent ECN model which supports
enhanced trade execution management and transaction cost analysis
as well as alpha generation. "With newly added capabilities in
European ordinaries and currencies, Knight Direct EMS offers a
robust platform to asset managers and hedge funds seeking
self-directed trading solutions to efficiently source liquidity
across multiple asset classes," said Mr. Wald. Knight Direct EMS is
offered through Knight's subsidiaries, Direct Trading
Institutional, L.P. and Knight Equity Markets International Ltd.
About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is a leading
financial services firm that provides electronic and voice access
to the capital markets across multiple asset classes for buy-side,
sell-side and corporate clients, and asset management for
institutions and private clients. Our Global Markets business
provides market access and trade execution services in nearly every
U.S. equity security and a large number of international
securities, futures, options, foreign exchange and fixed income. We
offer high-quality trade executions through natural liquidity,
capital facilitation and trading technology, with comprehensive
products and services that support alpha creation and capital
formation. Our Asset Management business, Deephaven Capital
Management, is a global multi-strategy alternative investment
manager focused on delivering attractive risk-adjusted returns with
low correlation to the broader markets. More information about
Knight can be found at http://www.knight.com/. Certain statements
contained herein, and the documents incorporated by reference, may
constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are not historical facts and are based
on current expectations, estimates and projections about the
Company's industry, management's beliefs and certain assumptions
made by management, many of which, by their nature, are inherently
uncertain and beyond our control. Accordingly, readers are
cautioned that any such forward-looking statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict
including, without limitation, risks associated with the costs,
integration, performance and operation of businesses recently
acquired, or that may be acquired in the future, by the Company.
Since such statements involve risks and uncertainties, the actual
results and performance of the Company may turn out to be
materially different from the results expressed or implied by such
forward-looking statements. Given these uncertainties, readers are
cautioned not to place undue reliance on such forward-looking
statements. Unless otherwise required by law, the Company also
disclaims any obligation to update its view of any such risks or
uncertainties or to announce publicly the result of any revisions
to the forward-looking statements made herein. Readers should
carefully review the risks and uncertainties disclosed in the
Company's reports with the U.S. Securities and Exchange Commission
(SEC), including, without limitation, those detailed under the
headings "Certain Factors Affecting Results of Operations" and
"Risk Factors" in the Company's Annual Report on Form 10-K for the
year- ended December 31, 2007, and in other reports or documents
the Company files with, or furnishes to, from time to time the SEC.
This information should also be read in conjunction with the
Company's Consolidated Financial Statements and the Notes thereto
contained in the Company's Annual Report on Form 10-K for the
year-ended December 31, 2007, and in other reports or documents the
Company files with, or furnishes to, from time to time the SEC.
DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas,
Senior Managing Director, Communications, Marketing & Investor
Relations, +1-201-557-6954, , or Kara Fitzsimmons, Director, Media
Relations, +1-201-356-1523, , or Ludwig Marek, Vice President,
Marketing Communications - Institutional Group, +1-201-356-1506, ,
all of Knight Capital Group, Inc. Web site: http://www.knight.com/
Copyright
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024